Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • COVID-19 & Cancer Resource Center
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Immunology Research
Cancer Immunology Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • COVID-19 & Cancer Resource Center
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Articles

Identification of tumor-restricted antigens NY-BR-1, SCP-1, and a new cancer/testis-like antigen NW-BR-3 by serological screening of a testicular library with breast cancer serum

Dirk Jäger, Marc Unkelbach, Claudia Frei, Florian Bert, Matthew J. Scanlan, Elke Jäger, Lloyd J. Old, Yao-Tseng Chen and Alexander Knuth
Dirk Jäger
1II. Medizinische Klinik, Hämatologie-Onkologie, Krankenhaus Nordwest, Frankfurt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc Unkelbach
1II. Medizinische Klinik, Hämatologie-Onkologie, Krankenhaus Nordwest, Frankfurt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claudia Frei
1II. Medizinische Klinik, Hämatologie-Onkologie, Krankenhaus Nordwest, Frankfurt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Florian Bert
1II. Medizinische Klinik, Hämatologie-Onkologie, Krankenhaus Nordwest, Frankfurt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew J. Scanlan
2Ludwig Institute for Cancer Research, New York Branch at Memorial Sloan-Kettering Cancer Center, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elke Jäger
1II. Medizinische Klinik, Hämatologie-Onkologie, Krankenhaus Nordwest, Frankfurt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lloyd J. Old
2Ludwig Institute for Cancer Research, New York Branch at Memorial Sloan-Kettering Cancer Center, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yao-Tseng Chen
2Ludwig Institute for Cancer Research, New York Branch at Memorial Sloan-Kettering Cancer Center, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander Knuth
1II. Medizinische Klinik, Hämatologie-Onkologie, Krankenhaus Nordwest, Frankfurt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published January 2002
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1

    NW-BR-3 cDNA sequence and predicted amino acid sequence. The translation initiation codon and the termination codon are underlined. The RT-PCR analysis was carried out with the primers AGCGGTTTGGCACCGTACAGC and AGCTGTGTCGCCTGCCTTTGTGC. The probe for Northern blotting and nucleotide screening was generated with the primers GAAAAGGAGGCAAGGAGACAGC and TGATGCTCACGGAACTACGGTG.

  • Figure 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2

    Alignment of the NW-BR-3 and mouse testis m-BR-3 predicted protein sequences. There is 70.5% amino acid homology between the two predicted polypeptides. The amino terminus of the human NY-BR-3 sequence is longer.

  • Figure 3
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3

    Northern Blot analysis of NW-BR-3 mRNA expression. (a) The NW-BR-3 probe hybridizes to a single mRNA species of approx. 1.9 kb. All other normal tissues do not yield a detectable signal. (b) Control hybridizations using an actin probe.

  • Figure 4
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4

    Analysis of NW-BR-3 mRNA expression by RT-PCR. In normal tissues, a strong signal is observed in testis, weak signals in brain, kidney, trachea, uterus, and prostate (a); all other tissues tested are negative. (b) and (c) NW-BR-3 expression in several tumors and tumor cell lines. ZR-75-1, MCF 7, SK-BR-3, and Cama are breast cancer cell lines; CRL 10995 is a prostate cancer cell line; Asc-1, SK OV-3, and NW0192 - NW0049 are ovarian cancer cell lines. Abbreviations: BC, breast cancer; MEL, melanoma; OC, ovarian cancer; PC, prostate cancer; RC, renal cancer; TCC, transitional cell cancer.

Tables

  • Figures
  • Table 1

     

    Antigens identified by SEREX.

    Designation No. of Clones GenBank UniGene Expression
    NW-BR-1 3 NY-BR-1 Hs.326736 breast, testis, breast cancer
    NW-BR-2 1 SCP-1 Hs.112743 `cancer/testis
    NW-BR-3 9 clone 18CGI1F2 Hs.339651 `cancer/testis-like
    NW-BR-4 1 KIAA1005 Hs.12328 ubiquitous
    NW-BR-5 1 KIAA0635 Hs.185091 ubiquitous
    NW-BR-6 2 LZ16 Hs.42390 ubiquitous
    NW-BR-7 1 PRDM5 Hs.192867 ubiquitous
    NW-BR-8 1 CTC-260F20 Hs.279574 ubiquitous
    NW-BR-9 1 TFNR Hs.272808 ubiquitous
    NW-BR-10 1 ROCK1 Hs.17820 ubiquitous
    NW-BR-11 1 MARKL1 Hs.118843 ubiquitous
    NW-BR-12 1 GCP3 Hs.9884 ubiquitous
    NW-BR-13 1 unknown Hs.125201 ubiquitous
PreviousNext
Back to top
Cancer Immunity Archive: 2 (1)
January 2002
Volume 2, Issue 1
  • Table of Contents

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Immunology Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Identification of tumor-restricted antigens NY-BR-1, SCP-1, and a new cancer/testis-like antigen NW-BR-3 by serological screening of a testicular library with breast cancer serum
(Your Name) has forwarded a page to you from Cancer Immunology Research
(Your Name) thought you would be interested in this article in Cancer Immunology Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Identification of tumor-restricted antigens NY-BR-1, SCP-1, and a new cancer/testis-like antigen NW-BR-3 by serological screening of a testicular library with breast cancer serum
Dirk Jäger, Marc Unkelbach, Claudia Frei, Florian Bert, Matthew J. Scanlan, Elke Jäger, Lloyd J. Old, Yao-Tseng Chen and Alexander Knuth
Cancer Immun January 1 2002 (2) (1) 5;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Identification of tumor-restricted antigens NY-BR-1, SCP-1, and a new cancer/testis-like antigen NW-BR-3 by serological screening of a testicular library with breast cancer serum
Dirk Jäger, Marc Unkelbach, Claudia Frei, Florian Bert, Matthew J. Scanlan, Elke Jäger, Lloyd J. Old, Yao-Tseng Chen and Alexander Knuth
Cancer Immun January 1 2002 (2) (1) 5;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Results
    • Discussion
    • Materials and methods
    • Acknowledgments
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • NY-ESO-1–specific immunological pressure and escape in a patient with metastatic melanoma
  • Hsp72 mediates stronger antigen-dependent non-classical MHC class Ib anti-tumor responses than hsc73 in Xenopus laevis
  • Human ovarian tumor ascites fluids rapidly and reversibly inhibit T cell receptor-induced NF-κB and NFAT signaling in tumor-associated T cells
Show more Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Cancer Immunology Essentials

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Immunology Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Immunology Research
eISSN: 2326-6074
ISSN: 2326-6066

Advertisement